A national model of remote care for assessing and providing opioid agonist treatment during the COVID-19 pandemic: a report
Abstract Background Health services globally are struggling to manage the impact of COVID-19. The existing global disease burden related to opioid use is significant. Particularly challenging groups include older drug users who are more vulnerable to the effects of COVID-19. Increasing access to saf...
Main Authors: | Des Crowley, Ide Delargy |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2020-07-01
|
Series: | Harm Reduction Journal |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s12954-020-00394-z |
Similar Items
-
Optimising treatment in opioid dependency in primary care: results from a national key stakeholder and expert focus group in Ireland
by: Marie Claire Van Hout, et al.
Published: (2018-06-01) -
Prevalence of alcohol consumption among clients of opioid agonist treatment (OAT) centers in Golestan province, Iran
by: Alireza Noroozi, et al.
Published: (2023-05-01) -
The relationship between opioid agonist therapy satisfaction and fentanyl exposure in a Canadian setting
by: Lindsay Mackay, et al.
Published: (2021-04-01) -
Virtual opioid agonist treatment: Alberta’s virtual opioid dependency program and outcomes
by: Nathaniel Day, et al.
Published: (2022-07-01) -
Mental disorders and suicidality among Opioid Agonist Treatment service users in Nepal: A cross sectional study
by: Sagun Ballav Pant, et al.
Published: (2022-12-01)